Tsukuba, Japan

Takayuji Inoue

This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takayuji Inoue. Retrieved from https://idiyas.com/inventor/takayuji-inoue

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Takayuji Inoue

Introduction

Takayuji Inoue is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target hypertension. His work has led to the creation of valuable therapeutic agents that can improve patient outcomes.

Latest Patents

Inoue holds a patent for "Angiotensin II antagonizing heterocyclic derivatives." This invention relates to compounds characterized by a specific formula, wherein certain variables represent a condensed or uncondensed imidazolyl ring. These compounds serve as angiotensin II antagonists, which are useful for treating hypertension and related conditions. He has 1 patent to his name.

Career Highlights

Inoue is associated with Fujisawa Pharmaceutical Company, Ltd., where he has contributed to various research and development projects. His expertise in pharmacology and chemistry has been instrumental in advancing the company's product offerings.

Collaborations

Inoue has worked alongside talented colleagues, including Teruo Kyoto Oku and Hiroyuki Setoi. Their collaborative efforts have fostered innovation and enhanced the research capabilities within their organization.

Conclusion

Takayuji Inoue's contributions to the field of pharmaceuticals, particularly through his patent on angiotensin II antagonists, highlight his role as an influential inventor. His work continues to impact the treatment of hypertension, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…